Researchers at The University of Texas MD Anderson Cancer Center have identified blood-based biomarkers that can help distinguish patients with glioblastoma who are most likely to live longer from ...
Results from a pilot clinical trial evaluating the safety and feasibility of repeated focused ultrasound-induced blood–brain barrier (BBB) opening combined with the monoclonal antibody drug Avastin ...
Scientists at the University of Virginia School of Medicine are chasing a new way to slow glioblastoma, the deadliest brain ...
Researchers identified blood-based biomarkers that predict which glioblastoma patients respond best to the oncolytic virus ...
Glioblastoma (GBM) is a rare and deadly disease: roughly 12,000 new patients are diagnosed every year in the US, a country of 330 million people. Most GBM patients die within 15 months and fewer than ...
LOS ANGELES--(BUSINESS WIRE)--Global Coalition for Adaptive Research (GCAR) today announced an update on the progress of GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment - ...
July 20 is Glioblastoma Day, which helps raise awareness of one of the rarest and deadliest forms of brain cancer. The average length of survival for patients after being diagnosed is eight months, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results